113 related articles for article (PubMed ID: 38606779)
1. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
Laurie C; El-Zein M; Tota JE; Tellier PP; Coutlée F; Burchell AN; Franco EL
J Med Virol; 2024 Apr; 96(4):e29604. PubMed ID: 38606779
[TBL] [Abstract][Full Text] [Related]
2. Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial.
Laurie C; Tota JE; El-Zein M; Tellier PP; Coutlée F; Burchell AN; Franco EL
Contemp Clin Trials; 2021 Nov; 110():106560. PubMed ID: 34487919
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.
Magnan S; Tota JE; El-Zein M; Burchell AN; Schiller JT; Ferenczy A; Tellier PP; Coutlée F; Franco EL;
Clin Microbiol Infect; 2019 Feb; 25(2):210-216. PubMed ID: 29684633
[TBL] [Abstract][Full Text] [Related]
4. Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men.
Kassam P; El-Zein M; Laurie C; Tota JE; Tellier PP; Coutlée F; de Pokomandy A; Franco EL
J Med Virol; 2024 Mar; 96(3):e29562. PubMed ID: 38528834
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a self-applied carrageenan-based gel to prevent human papillomavirus infection in sexually active young women (CATCH study): an exploratory phase IIB randomised, placebo-controlled trial.
Laurie C; El-Zein M; Botting-Provost S; Tota JE; Tellier PP; Coutlée F; Burchell AN; Franco EL
EClinicalMedicine; 2023 Jun; 60():102038. PubMed ID: 37396806
[TBL] [Abstract][Full Text] [Related]
6. Changes in type-specific human papillomavirus load predict progression to cervical cancer.
Depuydt CE; Criel AM; Benoy IH; Arbyn M; Vereecken AJ; Bogers JJ
J Cell Mol Med; 2012 Dec; 16(12):3096-104. PubMed ID: 22978795
[TBL] [Abstract][Full Text] [Related]
7. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
[TBL] [Abstract][Full Text] [Related]
8. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
[No Abstract] [Full Text] [Related]
9. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.
Lai HC; Peng MY; Nieh S; Yu CP; Chang CC; Lin YW; Sun CA; Chu TY
Int J Gynecol Cancer; 2006; 16(2):730-5. PubMed ID: 16681753
[TBL] [Abstract][Full Text] [Related]
10. Initial viral load in cases of single human papillomavirus 16 or 52 persistent infection is associated with progression of later cytopathological findings in the uterine cervix.
Hamaguchi D; Miura K; Abe S; Kinoshita A; Miura S; Yamasaki K; Yoshiura K; Masuzaki H
J Med Virol; 2013 Dec; 85(12):2093-100. PubMed ID: 23960027
[TBL] [Abstract][Full Text] [Related]
11. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.
Del Río-Ospina L; Soto-De León SC; Camargo M; Moreno-Pérez DA; Sánchez R; Pérez-Prados A; Patarroyo ME; Patarroyo MA
BMC Cancer; 2015 Mar; 15():100. PubMed ID: 25885207
[TBL] [Abstract][Full Text] [Related]
12. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
13. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.
Xi LF; Schiffman M; Hughes JP; Galloway DA; Koutsky LA; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1388-1394. PubMed ID: 31101617
[TBL] [Abstract][Full Text] [Related]
14. Detection, genotyping and quantitation of multiple hpv infections in south African women with cervical squamous cell carcinoma.
Lebelo RL; Bogers JJ; Thys S; Depuydt C; Benoy I; Selabe SG; Bida MN; Mphahlele MJ
J Med Virol; 2015 Sep; 87(9):1594-600. PubMed ID: 26037775
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification.
Laurie C; El-Zein M; Franco EL; Coutlée F
J Med Virol; 2021 Nov; 93(11):6408-6411. PubMed ID: 33760280
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a carrageenan gel in preventing anal human papillomavirus (HPV) infection: interim analysis of the Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV) randomised controlled trial.
Laurie C; El-Zein M; Tota JE; Khosrow-Khavar F; Tellier PP; Coutlée F; de Pokomandy A; Franco EL;
Sex Transm Infect; 2022 Jun; 98(4):239-246. PubMed ID: 34140405
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.
Hildesheim A; Herrero R; Wacholder S; Rodriguez AC; Solomon D; Bratti MC; Schiller JT; Gonzalez P; Dubin G; Porras C; Jimenez SE; Lowy DR;
JAMA; 2007 Aug; 298(7):743-53. PubMed ID: 17699008
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a Carrageenan Gel in Increasing Clearance of Anal Human Papillomavirus Infections in Men: Interim Analysis of a Double-Blind, Randomized Controlled Trial.
Laurie C; El-Zein M; Tota J; Khosrow-Khavar F; Tellier PP; Coutlée F; de Pokomandy A; Franco EL;
J Infect Dis; 2023 Feb; 227(3):402-406. PubMed ID: 35090175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
